Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end

The world’s biggest miner is trying to figure out if tiny rock-eating microbes can help it solve a

(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to

Australia has approved its first thermal coal project since Prime Minister Anthony Albanese came to power, drawing criticism

Tourists and business travelers to Japan will soon be able to show up with little more than the

HSBC Holdings Plc will become the first British bank to test an advanced data-security system being run by

An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The

Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in

Ryan Seacrest signed a multiyear agreement with Sony Pictures Television to become the new host of Wheel of

New health warnings by Ireland set to be the world’s strictest on beer, wine and spirits have sparked

A type of charcoal first used by Amazonian tribes thousands of years ago is becoming a key component